Peptide Academy · Growth
Also known as ActRIIB-Fc decoy receptor
Educational research summary, not medical advice. Many compounds here are not approved for human use. Talk to a licensed clinician before making any health decision.
The Peptide Academy is free to read. Members also get the research protocols for ACE-031, dose and vial tracking, and an AI Advisor with cited sources. Try it all free for 7 days, no card needed.
Start my free 7-day trialA soluble activin receptor that blocks myostatin and related ligands, developed for muscular dystrophy.
Acts as a decoy receptor binding myostatin/activins before they reach muscle ActRIIB receptors, releasing the brake on muscle growth.
~10–14 days (activin receptor fusion protein)
Development discontinued; WADA-prohibited.
Common side effects
Histamine reactions
Possible at the injection site, as with most injected peptides.
Common fixes
Stop and get help
Basis: Limited data; general experience with injected peptides. Educational only, not medical advice.
Prescription medicines in general
No human interaction studies exist for this compound, so its interaction profile is unknown. Unknown is not the same as safe.
Everything else you take, including supplements
Bring a full list of medicines and supplements to your pharmacist or clinician before starting.
Basis: No published human interaction data. Educational only, not medical advice. Never stop or change a prescribed medicine without your prescriber.
Protocols & tracking are members-only
Members see the research protocols for ACE-031, plan schedules, track every dose and vial, and ask the AI Advisor questions with cited sources. Try every Researcher feature free for 7 days, no card needed.